MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine, Drug Discovery, Development & Delivery
*Bioscience Regional Clusters & HotSpots
*Industry: Massachusetts
Be Biopharma
Organization & Developments: Be Biopharma
Parents
Be Biopharma
Children
*B cells are prolific protein producers that can be collected from peripheral blood, have a programmable lifetime that could last decades, can target specific tissues, and have broad, customizable functionality
*Be Bio’s focus is to build a new class of engineered B cell medicines that will provide direct control over the power of humoral immunity and transform the prognosis for patients across a range of diseases who currently have limited treatment options
*Builds on the research conducted at Seattle Children’s Research Institute conducted by company co-founders David Rawlings and Richard James
2021: Be Bio Brings in New Talent for Top Roles
Jumps
Finance & Acquisition: Be Biopharma
Key People: Be Biopharma